Is telehealth allowed to prescribe Strattera in Florida?

In today’s fast-paced world, telehealth has revolutionized how we access healthcare, particularly for conditions like ADHD. If you’re considering a non-stimulant medication like Strattera (atomoxetine) for ADHD treatment but prefer the convenience of telehealth, you’ll be pleased to know that in most cases, this is entirely possible. But navigating the regulatory landscape can be confusing. Let’s break down exactly what you need to know about getting non-stimulant ADHD medications through telehealth services.

The Good News: Non-Stimulants Are Telehealth-Friendly

Strattera and other non-stimulant ADHD medications can be prescribed via telehealth in all 50 states, with few restrictions. The key reason? Strattera (atomoxetine) is not a controlled substance, which means it doesn’t fall under the strict DEA regulations that govern stimulant medications like Adderall or Ritalin.

This classification difference is crucial because:

• No federal in-person examination requirement exists for non-stimulant prescriptions
• Prescriptions can include refills (unlike Schedule II stimulants that need a new prescription each month)
• Doctors can prescribe up to a 90-day supply at once, reducing the frequency of appointments
• There’s no risk of physical dependence, making telehealth monitoring appropriate

As Dr. Sarah Bennett, a psychiatrist at Klarity Health, explains: ‘Non-stimulants offer a safe, effective option for many patients with ADHD who may not do well on stimulants or prefer not to take a controlled medication. The fact that we can prescribe these medications via telehealth without the same restrictions as stimulants makes treatment more accessible for many patients.’

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal vs. State Regulations: What You Should Know

While federal law doesn’t restrict telehealth prescribing of non-stimulants, state laws can add additional requirements. However, for non-stimulant ADHD medications specifically, most states impose no special restrictions.

Federal Rules

The DEA’s current telehealth rules primarily affect stimulant medications (Schedule II controlled substances). These current flexibilities are temporary and extend through December 31, 2025, allowing telehealth prescribing of controlled substances without an in-person exam. However, these rules don’t impact non-stimulants like Strattera at all, since they’ve never been restricted at the federal level.

State-by-State Overview

Let’s look at how several key states approach telehealth for non-stimulant ADHD medications:

California

• ✅ Telehealth allowed for non-stimulant ADHD medications
• ❌ No in-person visit required for non-controlled medications
• ✅ NPs can prescribe independently after meeting experience requirements

New York

• ✅ Telehealth allowed for non-stimulant ADHD medications
• ❌ No in-person visit required for non-controlled medications
• ⚠️ Note: NY did implement an in-person requirement for controlled substances in 2025, but this doesn’t affect non-stimulants like Strattera

Florida

• ✅ Telehealth allowed for non-stimulant ADHD medications
• ❌ No in-person visit required for non-controlled medications
• ✅ NPs can prescribe with physician collaboration

Texas

• ✅ Telehealth allowed for non-stimulant ADHD medications
• ❌ No in-person visit required for non-controlled medications
• ✅ NPs can prescribe non-controlled medications with physician supervision

Alabama (strictest state)

• ✅ Telehealth allowed for non-stimulant ADHD medications
• ⚠️ Annual in-person visit recommended for ongoing telehealth care (with exceptions for mental health services)
• ✅ NPs can prescribe non-controlled medications with collaboration

The Telehealth ADHD Evaluation Process

When you seek ADHD treatment through telehealth, you can expect a thorough evaluation process similar to an in-person visit. Here’s what typically happens when you use a quality telehealth service like Klarity Health:

1. Initial Assessment: You’ll complete detailed questionnaires about your symptoms, history, and how ADHD affects different areas of your life.

2. Video Consultation: A licensed provider will conduct a comprehensive evaluation via video, following the same diagnostic criteria (DSM-5) used in in-person settings.

3. Diagnosis & Treatment Planning: If appropriate, your provider will discuss treatment options, including non-stimulant medications like Strattera, along with behavioral strategies.

4. Prescription: If Strattera or another non-stimulant is recommended, your provider can e-prescribe it directly to your local pharmacy.

5. Follow-up Care: Regular video appointments to monitor your progress, typically starting with more frequent check-ins (every 2-4 weeks) then transitioning to less frequent visits once stable.

‘We follow the same diagnostic standards and care protocols as in-person practices,’ notes Dr. James Miller of Klarity Health. ‘The only real difference is the convenience factor for the patient – they can receive expert care without the commute or waiting room.’

Common Questions About Telehealth and Non-Stimulant ADHD Medications

Can nurse practitioners prescribe non-stimulant ADHD medications via telehealth?

Yes, in all states, nurse practitioners and physician assistants can prescribe non-controlled substances like Strattera via telehealth, though in some states they require a collaborative agreement with a physician. The specifics vary by state:

• In states like New York and Illinois, NPs have independent practice authority
• In states like Texas, Florida, and Alabama, NPs require physician collaboration
• Even in states where NPs have restrictions for prescribing stimulants, they typically CAN prescribe non-stimulants

How is Strattera different from stimulant ADHD medications?

Strattera (atomoxetine) works differently than stimulants. Rather than directly increasing dopamine like Adderall or Ritalin, it works primarily by inhibiting the reuptake of norepinephrine, a neurotransmitter that helps with attention and impulse control.

Key differences include:

• Not a controlled substance – no risk of dependence or abuse
• Takes longer to work – full effects may take 4-6 weeks (versus same-day effects with stimulants)
• Continuous coverage – works 24/7 once at steady state (versus the ups and downs of stimulants)
• Different side effect profile – less impact on appetite and sleep, but may cause initial nausea
• No ‘wear-off’ periods – consistent symptom control throughout the day

Will my insurance cover telehealth ADHD treatment?

Most major insurance plans now cover telehealth visits for mental health conditions, including ADHD. Strattera is typically covered by insurance plans, though coverage varies. At Klarity Health, we work with most major insurance providers and can verify your coverage before treatment begins. We also offer transparent cash pricing for those without insurance.

How long does it take to get a prescription via telehealth?

With Klarity Health, most patients can book an appointment within days, not weeks. After your evaluation, if Strattera is appropriate for you, your prescription can be sent to your pharmacy the same day. Since Strattera is not a controlled substance, the process faces fewer regulatory hurdles than stimulant prescriptions.

Is telehealth ADHD treatment as effective as in-person care?

Research shows that telehealth is highly effective for ADHD diagnosis and treatment. A 2023 study in the Journal of Attention Disorders found no significant difference in treatment outcomes between patients receiving care via telehealth versus in-person appointments. For many patients, telehealth actually improves adherence to treatment plans because of the reduced barriers to attending appointments.

What to Look for in a Telehealth ADHD Provider

When seeking telehealth treatment for ADHD with non-stimulant medications, consider these factors:

1. Provider Credentials: Ensure the provider is licensed in your state and has experience treating ADHD.

2. Comprehensive Evaluation: The provider should conduct a thorough assessment, not just a quick questionnaire.

3. Treatment Options: They should discuss various treatment approaches, not just medication.

4. Follow-up Protocol: Regular check-ins should be part of the plan, especially when starting a new medication.

5. Insurance Acceptance: Check if they accept your insurance or offer affordable cash pricing.

Klarity Health meets all these criteria, with license

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment